uBriGene to Present at ESGCT 2026

uBriGene at ESGCT 2026 | Cell & Gene Therapy Innovation

uBriGene at AASCP 2026

uBriGene at AASCP 2026

uBriGene to Attend Meeting on the Mesa 2026

uBriGene to Attend Meeting on the Mesa 2026

uBriGene uVivo™ LVV at CAR-TCR Summit 2026

uBriGene Showcases uVivo™LVV at 11th CAR-TCR Summit 2026

uBriGene at ISSCR 2026 | circRNA-LNP iPSC Reprogramming

Meet uBriGene at ISSCR 2026: Advancing iPSC Reprogramming with circRNA-LNP Technology

uBriGene uVivo™ LVV Platform at ASGCT 2026

uBriGene Showcases uVivo™ LVV—An IND-Ready In Vivo CAR-T Platform—at ASGCT 2026 Annual Meeting in Boston

uBriGene Highlights Innovative Platforms at ISCT 2026

uBriGene to Present circRNA-LNP and Lentiviral Manufacturing Innovations at ISCT 2026 in Dublin

uBriGene At Advanced Therapies Week 2026 | CGT Innovation

uBriGene to Drive Innovation in Cell & Gene Therapy at Advanced Therapies Week 2026 in San Diego

uBriGene at JPM 2026 | Cell & Gene Therapy Innovation

Where Science Meets Strategy: uBriGene Engages Global Leaders at JPM Healthcare Conference 2026

Advancing Lentiviral Vector Manufacturing at ASH 2025

uBriGene to Present High-Yield cGMP Lentiviral Vector Manufacturing Process at the 67th ASH Annual Meeting 2025